Literature DB >> 9770464

Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene.

D De Cesare1, S Jacquot, A Hanauer, P Sassone-Corsi.   

Abstract

Activation by growth factors of the Ras-dependent signaling cascade results in the induction of p90 ribosomal S6 kinases (p90(rsk)). These are translocated into the nucleus upon phosphorylation by mitogen-activated protein kinases, with which p90(rsk) are physically associated in the cytoplasm. In humans there are three isoforms of the p90(rsk) family, Rsk-1, Rsk-2, and Rsk-3, which are products of distinct genes. Although these isoforms are structurally very similar, little is known about their functional specificity. Recently, mutations in the Rsk-2 gene have been associated with the Coffin-Lowry syndrome (CLS). We have studied a fibroblast cell line established from a CLS patient that bears a nonfunctional Rsk-2. Here we document that in CLS fibroblasts there is a drastic attenuation in the induced Ser-133 phosphorylation of transcription factor CREB (cAMP response element-binding protein) in response to epidermal growth factor stimulation. The effect is specific, since response to serum, cAMP, and UV light is unaltered. Furthermore, epidermal growth factor-induced expression of c-fos is severely impaired in CLS fibroblasts despite normal phosphorylation of serum response factor and Elk-1. Finally, coexpression of Rsk-2 in transfected cells results in the activation of the c-fos promoter via the cAMP-responsive element. Thus, we establish a link in the transduction of a specific growth factor signal to changes in gene expression via the phosphorylation of CREB by Rsk-2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770464      PMCID: PMC22809          DOI: 10.1073/pnas.95.21.12202

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences.

Authors:  R Treisman
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

Review 2.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

3.  A versatile in vivo and in vitro eukaryotic expression vector for protein engineering.

Authors:  S Green; I Issemann; E Sheer
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 5.  The Coffin-Lowry syndrome.

Authors:  I D Young
Journal:  J Med Genet       Date:  1988-05       Impact factor: 6.318

6.  Transcriptional autoregulation of the proto-oncogene fos.

Authors:  P Sassone-Corsi; J C Sisson; I M Verma
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

Review 7.  Proto-oncogene fos: complex but versatile regulation.

Authors:  I M Verma; P Sassone-Corsi
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

8.  Antibodies to Xenopus egg S6 kinase II recognize S6 kinase from progesterone- and insulin-stimulated Xenopus oocytes and from proliferating chicken embryo fibroblasts.

Authors:  E Erikson; D Stefanovic; J Blenis; R L Erikson; J L Maller
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

9.  Modulation of c-fos gene transcription by negative and positive cellular factors.

Authors:  P Sassone-Corsi; I M Verma
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

10.  The c-fos serum response element responds to protein kinase C-dependent and -independent signals but not to cyclic AMP.

Authors:  M Z Gilman
Journal:  Genes Dev       Date:  1988-04       Impact factor: 11.361

View more
  61 in total

1.  RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2.

Authors:  Yuan Xiao Zhu; Hongwei Yin; Laura A Bruins; Chang-Xin Shi; Patrick Jedlowski; Meraj Aziz; Chris Sereduk; Klaus Martin Kortuem; Jessica E Schmidt; Mia Champion; Esteban Braggio; A Keith Stewart
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

2.  MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14.

Authors:  Ana Soloaga; Stuart Thomson; Giselle R Wiggin; Navita Rampersaud; Mark H Dyson; Catherine A Hazzalin; Louis C Mahadevan; J Simon C Arthur
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 3.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 4.  Joining the dots: from chromatin remodeling to neuronal plasticity.

Authors:  Loredana Zocchi; Paolo Sassone-Corsi
Journal:  Curr Opin Neurobiol       Date:  2010-05-12       Impact factor: 6.627

5.  Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

Authors:  Jean-Pierre David; Denis Mehic; Latifa Bakiri; Arndt F Schilling; Vice Mandic; Matthias Priemel; Maria Helena Idarraga; Markus O Reschke; Oskar Hoffmann; Michael Amling; Erwin F Wagner
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2.

Authors:  Li Wang; Xiangyu Wang; Hanyong Chen; Xueyin Zu; Fayang Ma; Kangdong Liu; Ann M Bode; Zigang Dong; Dong Joon Kim
Journal:  Phytother Res       Date:  2018-12-10       Impact factor: 5.878

7.  Characterization of a CREB gain-of-function mutant with constitutive transcriptional activity in vivo.

Authors:  K Du; H Asahara; U S Jhala; B L Wagner; M Montminy
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

8.  Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer.

Authors:  Nada Milosevic; Benjamin Kühnemuth; Leonie Mühlberg; Stefanie Ripka; Heidi Griesmann; Carolin Lölkes; Malte Buchholz; Daniela Aust; Christian Pilarsky; Sebastian Krug; Thomas Gress; Patrick Michl
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

9.  MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts.

Authors:  Giselle R Wiggin; Ana Soloaga; Julia M Foster; Victoria Murray-Tait; Philip Cohen; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

10.  Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1.

Authors:  Kasumi Murai; Richard Treisman
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.